Zou JJ - Search Results

1

Association of the use of amlodipine with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention.

Liu XQ, Lin S, Qiu LL, Lin L, Zhao YY, Xu HM, Zhang J, Zou JJ. Liu XQ, et al. Among authors: zou jj. Pharmazie. 2014 Nov;69(11):814-7. Pharmazie. 2014. PMID: 25985576

2

Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.

Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, Yang S, Ge Z, Shan SJ, Li XB, Xu T, Kan J, Lin L, Han YL. Chen SL, et al. Among authors: zou jj. Cardiovasc Ther. 2013 Aug;31(4):193-200. doi: 10.1111/j.1755-5922.2012.00319.x. Cardiovasc Ther. 2013. PMID: 22954234 Free article. Clinical Trial.

3

Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention.

Zou JJ, Xie HG, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Wang GJ. Zou JJ, et al. Eur J Clin Pharmacol. 2013 Apr;69(4):771-7. doi: 10.1007/s00228-012-1392-5. Epub 2012 Sep 22. Eur J Clin Pharmacol. 2013. PMID: 23001453 Clinical Trial.

4

Pharmacokinetics of clopidogrel in healthy Chinese volunteers.

Zou JJ, Ding L, Tan J, Fan HW, Wang GJ, Chen SL. Zou JJ, et al. Pharmazie. 2012 Sep;67(9):792-4. Pharmazie. 2012. PMID: 23016453

5

CYP2C19 681G > A polymorphism and pharmacokinetics of clopidogrel in Chinese healthy volunteers.

Zou JJ, Ding L, Tan J, He B, Wang GJ, Wang SK. Zou JJ, et al. Pharmazie. 2012 Sep;67(9):795-7. Pharmazie. 2012. PMID: 23016454

6

Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients.

Yang J, Zhou JS, Tan J, He BS, Zou JJ. Yang J, et al. Among authors: zou jj. Pharmazie. 2012 Dec;67(12):1026-9. Pharmazie. 2012. PMID: 23346768 Clinical Trial.

7

CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients.

Yang J, Zhao HD, Tan J, Ding YL, Gu ZQ, Zou JJ. Yang J, et al. Among authors: zou jj. Pharmazie. 2013 Mar;68(3):183-6. Pharmazie. 2013. PMID: 23556336

8

Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor.

Zou JJ, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Fan HW, Xie HG. Zou JJ, et al. PLoS One. 2014 Jan 8;9(1):e84985. doi: 10.1371/journal.pone.0084985. eCollection 2014. PLoS One. 2014. PMID: 24416326 Free PMC article.

9

The association of ABCC3 promoter methylation with clopidogrel response in Chinese ischemic stroke patients.

Yang J, Zhou JS, Zhang YD, Tian YY, Zou JJ. Yang J, et al. Among authors: zou jj. Pharmazie. 2014 Oct;69(10):764-8. Pharmazie. 2014. PMID: 25985567

10

ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients.

Yang J, Zhou JS, Zhao YX, Yang ZH, Zhao HD, Zhang YD, Zou JJ. Yang J, et al. Among authors: zou jj. Pharmazie. 2015 Feb;70(2):97-102. Pharmazie. 2015. PMID: 25997249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters